|
1
|
Cuschieri J and Maier RV: Oxidative
stress, lipid rafts, and macrophage reprogramming. Antioxid Redox
Signal. 9:1485–1497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lucas K and Maes M: Role of the Toll like
receptor (TLR) radical cycle in chronic inflammation: Possible
treatments targeting the TLR4 pathway. Mol Neurobiol. 48:190–204.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leiro J, Alvarez E, Arranz JA, Laguna R,
Uriarte E and Orallo F: Effects of cis-resveratrol on inflammatory
murine macrophages: Antioxidant activity and down-regulation of
inflammatory genes. J Leukoc Biol. 75:1156–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su YW, Chiou WF, Chao SH, Lee MH, Chen CC
and Tsai YC: Ligustilide prevents LPS-induced iNOS expression in
RAW 264.7 macrophages by preventing ROS production and
down-regulating the MAPK, NF-κB and AP-1 signaling pathways. Int
Immunopharmacol. 11:1166–1172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hong SH, Jeong HK, Han MH, Park C and Choi
YH: Esculetin suppresses lipopolysaccharide-induced inflammatory
mediators and cytokines by inhibiting nuclear factor-κB
translocation in RAW 264.7 macrophages. Mol Med Rep. 10:3241–3246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murakami A and Ohigashi H: Targeting NOX,
INOS and COX-2 in inflammatory cells: Chemoprevention using food
phytochemicals. Int J Cancer. 121:2357–2363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang GY, Taboada S and Liao J: Induced
nitric oxide synthase as a major player in the oncogenic
transformation of inflamed tissue. Methods Mol Biol. 512:119–156.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Norberg JK, Sells E, Chang HH, Alla SR,
Zhang S and Meuillet EJ: Targeting inflammation: Multiple
innovative ways to reduce prostaglandin E2. Pharm Pat
Anal. 2:265–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim J, Kim J and Bae JS: ROS homeostasis
and metabolism: A critical liaison for cancer therapy. Exp Mol Med.
48:e2692016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klapproth JM and Sasaki M: Bacterial
induction of proinflammatory cytokines in inflammatory bowel
disease. Inflamm Bowel Dis. 16:2173–2179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Striz I, Brabcova E, Kolesar L and
Sekerkova A: Cytokine networking of innate immunity cells: A
potential target of therapy. Clin Sci (Lond). 126:593–612. 2014.
View Article : Google Scholar
|
|
12
|
Endale M, Park SC, Kim S, Kim SH, Yang Y,
Cho JY and Rhee MH: Quercetin disrupts tyrosine-phosphorylated
phosphatidylinositol 3-kinase and myeloid differentiation factor-88
association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced
inflammatory mediators production in RAW 264.7 cells.
Immunobiology. 218:1452–1467. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang BP, Lin CH, Chen HM, Lin JT, Cheng
YF and Kao SH: AMPK activation inhibits expression of
proinflammatory mediators through downregulation of PI3K/p38 MAPK
and NF-κB signaling in murine macrophages. DNA Cell Biol.
34:133–141. 2015. View Article : Google Scholar
|
|
14
|
Jung JS, Choi MJ, Lee YY, Moon BI, Park JS
and Kim HS: Suppression of lipopolysaccharide-induced
neuroinflammation by morin via MAPK, PI3K/Akt, and PKA/HO-1
signaling pathway modulation. J Agric Food Chem. 65:373–382. 2017.
View Article : Google Scholar
|
|
15
|
Nakajima S and Kitamura M: Bidirectional
regulation of NF-κB by reactive oxygen species: A role of unfolded
protein response. Free Radic Biol Med. 65:162–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Y, Li W, Su ZY and Kong AN: The
complexity of the Nrf2 pathway: Beyond the antioxidant response. J
Nutr Biochem. 26:1401–1413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loboda A, Damulewicz M, Pyza E, Jozkowicz
A and Dulak J: Role of Nrf2/HO-1 system in development, oxidative
stress response and diseases: An evolutionarily conserved
mechanism. Cell Mol Life Sci. 73:3221–3247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang KA and Hyun JW: Oxidative stress,
Nrf2, and epigenetic modification contribute to anticancer drug
resistance. Toxicol Res. 33:1–5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Panossian A and Wikman G: Pharmacology of
Schisandra chinensis Bail.: An overview of Russian research and
uses in medicine. J Ethnopharmacol. 118:183–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang CQ, Luo RH, Yan JM, Li Y, Li XN, Shi
YM, Shang SZ, Gao ZH, Yang LM, Zheng YT, et al: Structure and
bioactivity of triterpenoids from the stems of Schisandra
sphenanthera. Arch Pharm Res. 37:168–174. 2014. View Article : Google Scholar
|
|
21
|
Xiao WL, Huang SX, Wang RR, Zhong JL, Gao
XM, He F, Pu JX, Lu Y, Zheng YT, Zheng QT, et al: Nortriterpenoids
and lignans from Schisandra sphenanthera. Phytochemistry.
69:2862–2866. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chun JN, Cho M, So I and Jeon JH: The
protective effects of Schisandra chinensis fruit extract and its
lignans against cardiovascular disease: A review of the molecular
mechanisms. Fitoterapia. 97:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huyke C, Engel K, Simon-Haarhaus B, Quirin
KW and Schempp CM: Composition and biological activity of different
extracts from Schisandra sphenanthera and Schisandra chinensis.
Planta Med. 73:1116–1126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SR, Lee MK, Koo KA, Kim SH, Sung SH,
Lee NG, Markelonis GJ, Oh TH, Yang JH and Kim YC:
Dibenzocyclooctadiene lignans from Schisandra chinensis protect
primary cultures of rat cortical cells from glutamate-induced
toxicity. J Neurosci Res. 76:397–405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang CP, Li GC, Shi YW, Zhang XC, Li JL,
Wang ZW, Ding F and Liang XM: Neuroprotective effect of schizandrin
A on oxygen and glucose deprivation/reperfusion-induced cell injury
in primary culture of rat cortical neurons. J Physiol Biochem.
70:735–747. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
E Q, Tang M, Zhang X, Shi Y, Wang D, Gu Y,
Li S, Liang X, Wang Z and Wang C: Protection of seven
dibenzocyclooctadiene lignans from Schisandra chinensis against
serum and glucose deprivation injury in SH-SY5Y cells. Cell Biol
Int. 39:1418–1424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song F, Zeng K, Liao L, Yu Q, Tu P and
Wang X: Schizandrin A inhibits microglia-mediated
neuroninflammation through inhibiting TRAF6-NF-κB and Jak2-Stat3
signaling pathways. PLoS One. 11:e01499912016. View Article : Google Scholar
|
|
28
|
Leong PK, Wong HS, Chen J, Chan WM, Leung
HY and Ko KM: Differential action between schisandrin A and
schisandrin B in eliciting an anti-inflammatory action: The
depletion of reduced glutathione and the induction of an
antioxidant response. PLoS One. 11:e01558792016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Checker R, Patwardhan RS, Sharma D, Menon
J, Thoh M, Bhilwade HN, Konishi T and Sandur SK: Schisandrin B
exhibits anti-inflammatory activity through modulation of the
redox-sensitive transcription factors Nrf2 and NF-κB. Free Radic
Biol Med. 53:1421–1430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park SY, Park SJ, Park TG, Rajasekar S,
Lee SJ and Choi YW: Schizandrin C exerts anti-neuroinflammatory
effects by upregulating phase II detoxifying/antioxidant enzymes in
microglia. Int Immunopharmacol. 17:415–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie Y, Hao H, Wang H, Guo C, Kang A and
Wang G: Reversing effects of lignans on CCl4-induced hepatic CYP450
down regulation by attenuating oxidative stress. J Ethnopharmacol.
155:213–221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ba Q, Cui C, Wen L, Feng S, Zhou J and
Yang K: Schisandrin B shows neuroprotective effect in
6-OHDA-induced Parkinson's disease via inhibiting the negative
modulation of miR-34a on Nrf2 pathway. Biomed Pharmacother.
75:165–172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong Q, Hou H, Wu J and Chen Y: The
Nrf2-ARE pathway is associated with Schisandrin b attenuating
benzo(a)pyrene-Induced HTR cells damages in vitro. Environ Toxicol.
31:1439–1449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao C, Chen H, Niu C, Hu J and Cao B:
Protective effect of Schizandrin B against damage of UVB irradiated
skin cells depend on inhibition of inflammatory pathways.
Bioengineered. 8:36–44. 2017. View Article : Google Scholar
|
|
35
|
Lee IC, Lee SM, Ko JW, Park SH, Shin IS,
Moon C, Kim SH and Kim JC: Role of mitogen-activated protein
kinases and nuclear factor-kappa B in
1,3-dichloro-2-propanol-induced hepatic injury. Lab Anim Res.
32:24–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim HK: Adenophora remotiflora protects
human skin keratinocytes against UVB-induced photo-damage by
regulating antioxidative activity and MMP-1 expression. Nutr Res
Pract. 10:371–376. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hernández-Ledesma B, Hsieh CC and de Lumen
BO: Antioxidant and anti-inflammatory properties of cancer
preventive peptide lunasin in RAW 264.7 macrophages. Biochem
Biophys Res Commun. 390:803–808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mittal M, Siddiqui MR, Tran K, Reddy SP
and Malik AB: Reactive oxygen species in inflammation and tissue
injury. Antioxid Redox Signal. 20:1126–1167. 2014. View Article : Google Scholar :
|
|
39
|
Kasahara E, Sekiyama A, Hori M, Hara K,
Takahashi N, Konishi M, Sato EF, Matsumoto S, Okamura H and Inoue
M: Mitochondrial density contributes to the immune response of
macrophages to lipopolysaccharide via the MAPK pathway. FEBS Lett.
585:2263–2268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee DH, Park JS, Lee YS, Sung SH, Lee YH
and Bae SH: The hypertension drug, verapamil, activates Nrf2 by
promoting p62-dependent autophagic Keap1 degradation and prevents
acetaminophen-induced cytotoxicity. BMB Rep. 50:91–96. 2017.
View Article : Google Scholar :
|
|
41
|
Pittalà V, Salerno L, Romeo G, Modica MN
and Siracusa MA: A focus on heme oxygenase-1 (HO-1) inhibitors.
Curr Med Chem. 20:3711–3732. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ryter SW and Choi AM: Targeting heme
oxygenase-1 and carbon monoxide for therapeutic modulation of
inflammation. Transl Res. 167:7–34. 2016. View Article : Google Scholar
|
|
43
|
Motterlini R and Foresti R: Heme
oxygenase-1 as a target for drug discovery. Antioxid Redox Signal.
20:1810–1826. 2014. View Article : Google Scholar
|
|
44
|
Szopa A, Ekiert R and Ekiert H: Current
knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia
vine) as a medicinal plant species: A review on the bioactive
components, pharmacological properties, analytical and
biotechnological studies. Phytochem Rev. 16:195–218. 2017.
View Article : Google Scholar :
|
|
45
|
Melhem A, Stern M, Shibolet O, Israeli E,
Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G, et al:
Treatment of chronic hepatitis C virus infection via antioxidants:
Results of a phase I clinical trial. J Clin Gastroenterol.
39:737–742. 2005. View Article : Google Scholar : PubMed/NCBI
|
